Drug Type Prophylactic vaccine, mRNA vaccine, Liposomal Drug |
Synonyms RNA-based Zika virus vaccine (nano-liposomal formulation/intradermal), Infectious Disease Research Institute, rvRNA-based Zika virus vaccine (Quratis), rvRNA-based Zika virus vaccine (intradermal nano-liposomal formulation, Nanopass microneedle), IDRI/ Quratis |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Zika Virus Infection | Discovery | South Korea | 15 Aug 2016 | |
| Zika Virus Infection | Discovery | United States | 15 Aug 2016 |





